New Study From Invitae Highlights the Importance of Multigene Genetic Testing for Uterine Cancer Patients
Results from one of the largest datasets in uterine cancer presented at The American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting
SAN FRANCISCO, May 3, 2019 -- (Healthcare Sales & Marketing Network) -- Resear... Diagnostics, Oncology Invitae Corp, precision medicine, uterine cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Genetics | Marketing | OBGYN | Pharmaceuticals | Study